Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Brigham and Women's Hospital · Harvard University
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
789
total citations
- FWCI
- 30.46
- Percentile
- 100%
- References
- 67
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Medicine
- Canakinumab
- Thrombosis
- Intensive care medicine
- Internal medicine
- Anakinra
- Disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.